Executive Director, Clinical Development

The Executive Director, Clinical Development at Mineralys Therapeutics will lead clinical programs focused on developing treatments for hypertension and related conditions. This role involves overseeing pivotal studies, shaping regulatory strategies, and ensuring submission readiness, all within a fully remote work environment.

Key responsibilities include designing and executing clinical trials, providing medical oversight for Phase 2/3 and registrational studies, and collaborating with cross-functional teams to achieve program milestones. The role also entails serving as the medical monitor, ensuring patient safety, and contributing to global regulatory interactions and submissions.

Candidates must possess an MD or equivalent medical degree, with board certification preferred in Internal Medicine, Cardiology, Nephrology, Endocrinology, or related fields. A minimum of 10 years of industry experience in clinical development, particularly in late-stage or registrational trials, is required. Experience in hypertension, cardiovascular, renal, or metabolic diseases is strongly preferred.

Mineralys Therapeutics offers a comprehensive benefits package, including medical, dental, vision, paid time off, and a 401(k) plan. Employees are also eligible to participate in incentive plans contingent on personal and company performance.

The company fosters a collaborative and inclusive culture, emphasizing flexibility and ownership in a dynamic biotech environment. Employees are encouraged to contribute to innovative solutions addressing unmet medical needs in cardiovascular and renal diseases.